Starpharma Holdings Limited SPHRF
SPHRF
Starpharma Holdings Limited BBIXF
Bonus BioGroup Ltd. CLYYF
Celyad Oncology S.A. FNCH
Finch Therapeutics Group, Inc. RVXCF
Resverlogix Corp. MRES
Institute of Biomedical Research Corp. ELVAF
Evolva Holding S.A. CLIFF
Cordlife Group Limited MBXBF
Microbix Biosystems Inc. PVCT
Provectus Biopharmaceuticals, Inc.
Starpharma Holdings Limited BBIXF
Bonus BioGroup Ltd. CLYYF
Celyad Oncology S.A. FNCH
Finch Therapeutics Group, Inc. RVXCF
Resverlogix Corp. MRES
Institute of Biomedical Research Corp. ELVAF
Evolva Holding S.A. CLIFF
Cordlife Group Limited MBXBF
Microbix Biosystems Inc. PVCT
Provectus Biopharmaceuticals, Inc.
Performance
| Periode | SPHRF | BBIXF | CLYYF | FNCH | RVXCF | MRES | ELVAF | CLIFF | MBXBF | PVCT |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 257.14 % | 79 900.00 % | -64.00 % | 2.23 % | 138.10 % | -62.08 % | 22.22 % | -40.80 % | -23.36 % | -22.69 % |
| YTD | 255.11 % | 300.00 % | -26.53 % | 17.70 % | 75.44 % | -76.55 % | 22.22 % | -65.86 % | -43.25 % | -49.92 % |
| 1Y | 400.00 % | 300.00 % | -26.53 % | 23.15 % | 80.18 % | -61.44 % | 22.22 % | -65.86 % | -42.44 % | -51.33 % |
| 3Y | -28.57 % | 60.00 % | -65.62 % | 23.15 % | -38.65 % | -72.09 % | -92.67 % | -53.71 % | -44.76 % | -48.40 % |
| 5Y | -77.88 % | -11.11 % | -96.19 % | -97.92 % | -92.21 % | -43.13 % | -97.99 % | -63.18 % | -49.87 % | 2.20 % |
| 10Y | -48.98 % | -37.79 % | -99.75 % | -97.92 % | -95.19 % | -67.50 % | -99.60 % | -89.60 % | -33.60 % | -85.29 % |
| From the beginning | -28.57 % | -37.79 % | -99.68 % | -97.92 % | -97.67 % | -100.00 % | -99.61 % | -80.59 % | -65.11 % | -100.00 % |